Holen Sie sich die Stockscreener-App
3.13
1.88%
-0.06
Handel nachbörslich:
3.13
Adc Therapeutics Sa Aktie (ADCT) Neueste Nachrichten
ADC Therapeutics (NYSE:ADCT) Given "Buy" Rating at Guggenheim - MarketBeat
Is ADC Therapeutics SA the Top Chart Pick This WeekMarket Volume Summary & Free Weekly Watchlist of Top Performers - beatles.ru
Is It Too Late to Sell ADC Therapeutics SAWeekly Stock Report & Low Drawdown Momentum Trade Ideas - beatles.ru
ADC Therapeutics Reports Q2 2025 Financial Results: Earnings Breakdown and Strategic Maneuvers - AInvest
ADC Therapeutics (NYSE:ADCT) Announces Quarterly Earnings Results, Misses Expectations By $0.14 EPS - MarketBeat
ADC Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update - BioSpace
ADC Therapeutics S.A. (NYSE:ADCT) Q2 2025 Earnings Call Transcript - Insider Monkey
ADC Therapeutics 2025 Q2 Earnings Deeper Losses Amid Revenue Growth - AInvest
MACD Cross Could Confirm Trend in ADC Therapeutics SA2025 Biggest Moves & Real-Time Buy Signal Notifications - metal.it
ADC Therapeutics SA (ADCT) Q2 2025 Earnings Call Highlights: Revenue Growth Amid Strategic ... By GuruFocus - Investing.com Canada
ADC Therapeutics Q2 2025 Earnings Call Transcript - MarketBeat
ADC Therapeutics SA (ADCT) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
ADC Therapeutics targets $600M–$1B peak revenue potential for ZYNLONTA amid strategic refocus and cost cuts - MSN
Transcript : ADC Therapeutics SA, Q2 2025 Earnings Call, Aug 12, 2025 - MarketScreener
ADC Therapeutics SA reports results for the quarter ended June 30Earnings Summary - TradingView
ADC Therapeutics SA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
ADC Therapeutics Reports Second Quarter 2025 Financial Results - TradingView
Can ADC Therapeutics SA weather a recessionConsistent Triple Digit Profits - mustnews.co.kr
Using data models to predict ADC Therapeutics SA stock movementPortfolio Positioning Strategy With Timing - Newser
How to recover losses in ADC Therapeutics SA stockSafe Entry Screening with Data Backed Analysis - Newser
Can volume confirm reversal in ADC Therapeutics SASwing Trade Timing with Daily Forecast - Newser
Will ADC Therapeutics SA stock go up soonWeekly Hot Stocks Based on Volume Flow - Newser
Will ADC Therapeutics SA continue its uptrendFree Value Investing Picks With Stability - Newser
Pattern recognition hints at ADC Therapeutics SA upsideAlpha Trade Flow With Risk Calibration - Newser
Earnings visualization tools for ADC Therapeutics SAFree Weekly Return Pick Forecast Reports - Newser
Is ADC Therapeutics SA reversing from oversold territoryRSI and MACD Signal Summary with Trends - Newser
ADC Therapeutics to Host Second Quarter 2025 Financial Results Conference Call on August 12, 2025 - 富途牛牛
Bank of New York Mellon Corp Decreases Stock Holdings in ADC Therapeutics SA (NYSE:ADCT) - Defense World
What’s next for ADC Therapeutics SA stock pricePredictive Analytics for Equity Growth Potential - Newser
Are Medical Stocks Lagging ADC Therapeutics (ADCT) This Year? - sharewise.com
What makes ADC Therapeutics SA stock price move sharplySmart Trade Mapping with Entry Details - Newser
Chondrosarcoma Market: Epidemiology, Pipeline Products, Companies Working, Delveinsight Aadi Bioscience Inc, Acrotech Biopharma LLC, ADC Therapeutics SA, Advenchen Laboratories LLC, Alkermes Plc, As - Menafn
How strong is ADC Therapeutics SA company’s balance sheetCapitalize on emerging growth stocks - Jammu Links News
What is ADC Therapeutics SA company’s growth strategyGet alerts on high-potential stock breakouts - Jammu Links News
How volatile is ADC Therapeutics SA stock compared to the marketMaximize portfolio value with expert tips - Jammu Links News
Does ADC Therapeutics SA stock perform well during market downturnsGet daily updates on top-performing stocks - Jammu Links News
Should I hold or sell ADC Therapeutics SA stock in 2025Achieve rapid growth with smart investments - Jammu Links News
What institutional investors are buying ADC Therapeutics SA stockConsistent triple-digit returns - Jammu Links News
What is the dividend policy of ADC Therapeutics SA stockUnlock exclusive trading strategies for gains - Jammu Links News
ADC Therapeutics (ADCT) to Release Quarterly Earnings on Tuesday - Defense World
Is ADC Therapeutics SA stock overvalued or undervaluedGet daily updates on promising stocks - Jammu Links News
Why ADC Therapeutics SA stock attracts strong analyst attentionEquity Forecast with Predictive AI Screener - Newser
How does ADC Therapeutics SA generate profit in a changing economyLightning-fast growth - Jammu Links News
What are the latest earnings results for ADC Therapeutics SAInvest smarter with actionable trading signals - Jammu Links News
What are ADC Therapeutics SA company’s key revenue driversUnlock high-yield investment opportunities - Jammu Links News
What is the risk reward ratio of investing in ADC Therapeutics SA stockAchieve rapid capital gains with smart investing - Jammu Links News
Earnings Beat: ADC Therapeutics SA (NYSE:ADCT) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts - 富途牛牛
ADC Therapeutics (ADCT) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Adc Therapeutics shares rise 11.52% after-hours after granting options to new employees. - AInvest
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan - StreetInsider
ADC Therapeutics SA expected to post a loss of 47 cents a shareEarnings Preview - TradingView
0.41%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):